Anaphylaxis for UKMLA and PLAB 1: from first dose to discharge
Anaphylaxis is a sudden airway, breathing or circulation problem after a trigger, usually with skin or mucosal changes, which are absent in up to 20% of cases. Give IM adrenaline 1 mg/mL: 500 micrograms (0.5 mL) for adults and children over 12, into the anterolateral thigh, repeated after 5 minutes if there's no improvement. Still unwell after two doses means refractory anaphylaxis. Antihistamines and steroids aren't first-line.
| Recognise | Sudden A, B or C problem after a trigger |
|---|---|
| No rash? | Still possible: absent in up to 20% |
| First drug | IM adrenaline, 1 mg/mL (1:1000) |
| Adult dose | 500 micrograms = 0.5 mL |
| Site | Anterolateral thigh |
| No better at 5 minutes | Repeat the IM dose |
| 2 doses, still unwell | Refractory: expert help + IV infusion |
| Fluids | Adult 500–1000 mL · child 10 mL/kg |
| Tryptase | ASAP, then 1–2 h (by 4 h) |
| Discharge | 2 auto-injectors + allergy referral |
Anaphylaxis is one of the few topics where UK written exams expect a reflex, not a deliberation. The scenario changes (a child at a birthday party, a man stung in his garden, a patient five minutes into an IV antibiotic, a woman who collapses in the GP waiting room after her injection), but the question underneath is nearly always the same: do you recognise it, and do you give the right drug, at the right dose, by the right route, first? The options are written to tempt you with things that feel helpful: an antihistamine, a steroid, a nebuliser, or a dramatic IV bolus. Only one of them saves the patient in the next five minutes.
This guide is the long version of HIGH-YIELD 100 · 04/100, the fourth post in our series on the topics UK written exams keep coming back to. It is written for UKMLA AKT candidates, PLAB 1 candidates and UK medical students preparing for finals. Every clinical point was checked in October 2026 against the Resuscitation Council UK (RCUK) guideline Emergency treatment of anaphylaxis (May 2021, still the current version and reaffirmed in the RCUK 2025 Resuscitation Guidelines) and NICE guideline NG258, Anaphylaxis: assessment and referral after emergency treatment, which updated and replaced CG134 in 2026.
Recognise it: sudden onset plus an A, B or C problem
RCUK's definition is deliberately practical. You are looking for three things together:
- Sudden onset and rapid progression of symptoms, usually within minutes of the trigger.
- Life-threatening airway and/or breathing and/or circulation problems.
- Skin and/or mucosal changes (flushing, urticaria, angioedema), which are usually present.
The A, B and C problems are what make it anaphylaxis rather than a simple allergic reaction:
- Airway: Swelling of the throat or tongue, difficulty swallowing, hoarse voice, stridor (a high-pitched noise on breathing in)
- Breathing: Increased work of breathing, wheeze or a persistent cough, tiring, SpO2 below 94%, confusion or cyanosis from hypoxia
- Circulation: Pale and clammy, significant tachycardia, low blood pressure, dizziness, drowsiness or collapse
Two rules cause the most mistakes in exams:
- No rash does not rule it out. RCUK states that skin and mucosal changes can be subtle or absent in up to 20% of reactions. A patient who becomes wheezy and hypotensive straight after an IV drug, with no rash at all, can still have anaphylaxis.
- A rash alone is not anaphylaxis. Urticaria and lip swelling without an airway, breathing or circulation problem is an allergic reaction. It still needs treating (often with a non-sedating oral antihistamine) and observing, but it does not need adrenaline.
The common triggers in UK practice are foods (peanuts, tree nuts, milk, egg, shellfish), drugs (antibiotics, especially penicillins, neuromuscular blocking agents, NSAIDs, contrast media) and insect stings. Food is the commonest cause in young people; in the peri-operative setting, antibiotics and neuromuscular blocking agents lead the list. The question usually gives you the trigger in the first line.
The main differentials are worth naming because they appear as distractors. A vasovagal episode causes pallor and a slow pulse with no rash and no wheeze, and the patient improves lying flat. A panic attack causes hyperventilation and tingling with normal blood pressure. Acute severe asthma causes wheeze without urticaria, hypotension or a clear trigger. Hereditary angioedema causes swelling without urticaria and responds poorly to adrenaline. When the clinical picture fits anaphylaxis, though, RCUK's advice is unambiguous: if in doubt, treat it as anaphylaxis.
First actions: IM adrenaline, into the thigh
The order of the first few minutes matters, and exams test it.
Call for help and remove the trigger. Stop the infusion of the suspected drug. After a bee sting, flick or scrape the stinger out quickly (speed matters more than method). Don't try to make the patient vomit after a food trigger.
Position the patient. RCUK warns that death can occur within minutes if a patient with anaphylaxis stands, walks or sits up suddenly, because the circulation is so dependent on venous return. Lie them flat, with the legs raised if the blood pressure is low. A patient with airway or breathing problems may prefer to sit semi-recumbent, which makes breathing easier. Never stand or walk them.
Give IM adrenaline. This is the single most important step. RCUK's doses, all using adrenaline 1 mg/mL (1:1000) given intramuscularly:
- Adults and children over 12 years: IM adrenaline dose: 500 micrograms · Volume of 1 mg/mL: 0.5 mL
- Children 6–12 years: IM adrenaline dose: 300 micrograms · Volume of 1 mg/mL: 0.3 mL
- Children 6 months to 6 years: IM adrenaline dose: 150 micrograms · Volume of 1 mg/mL: 0.15 mL
- Infants under 6 months: IM adrenaline dose: 100–150 micrograms · Volume of 1 mg/mL: 0.1–0.15 mL
RCUK adds that a small or prepubertal child over 12 may be given 300 micrograms. Inject into the anterolateral aspect of the middle third of the thigh, where absorption is reliable, and repeat after 5 minutes if the airway, breathing or circulation problems persist. You don't need IV access to give it, and you shouldn't wait for IV access before giving it. The RCUK key recommendation is simple: if in doubt, give IM adrenaline. RCUK notes that a single dose of IM adrenaline is well tolerated and poses minimal risk, and that adverse effects are extremely rare with correct IM doses; the IM route is safer than the IV route.
Why the thigh and not the deltoid? Absorption from the vastus lateralis is faster and more predictable, and the thigh is where auto-injectors are designed to go. Exams sometimes offer "IM adrenaline into the deltoid" or "subcutaneous adrenaline" as a near-miss distractor.
Then support the ABCs. Once adrenaline is in:
- give the highest concentration of oxygen possible using a mask with a reservoir, then titrate to a target SpO2 of 94–98% (88–92% if the patient is at risk of hypercapnic respiratory failure);
- get IV access and attach monitoring: pulse oximetry, ECG and blood pressure;
- give a rapid IV crystalloid bolus if the patient is hypotensive or shocked (see section 3).
Still unwell after two IM doses? Refractory anaphylaxis
RCUK defines refractory anaphylaxis as respiratory or cardiovascular problems that persist despite two appropriate doses of IM adrenaline. It is uncommon, but it is a specific branch of the 2021 algorithm and a favourite exam question about escalation.
The management is:
- Get expert help early. Call critical care (and anaesthetics if the airway is at risk). Refractory anaphylaxis needs people who can manage the airway and run vasoactive infusions.
- A low-dose IV adrenaline infusion, started by an experienced specialist in an appropriate setting. RCUK is explicit that IV adrenaline should be given only by those skilled and experienced in its use; experience of giving adrenaline in cardiac arrest is not enough.
- Keep giving IM adrenaline every 5 minutes while the infusion is being set up, or if IV adrenaline can't be given safely.
- IV fluids, generously. Give a rapid crystalloid bolus of 500–1000 mL in adults or 10 mL/kg in children, and repeat it as needed; RCUK notes that adults in severe shock may need 3–5 litres. Use a non-glucose, sodium-containing crystalloid such as 0.9% sodium chloride or Hartmann's solution. Colloids are not recommended, and a colloid infusion that might be the trigger should be stopped.
The single most important "don't": IV adrenaline boluses are not recommended for anaphylaxis unless the patient is in cardiac arrest. The 1 mg IV dose that you learned for cardiac arrest is ten times the IM dose given straight into a vein of a patient with a pulse. It can cause severe hypertension, arrhythmias and myocardial ischaemia. If the patient does arrest, you follow the advanced life support algorithm and that is when 1 mg IV adrenaline is given.
Two specialist details occasionally appear at finals level. Adrenaline may work less well in patients taking beta-blockers, and in that situation RCUK suggests specialists consider glucagon when the reaction remains refractory to an adrenaline infusion and adequate fluids. Ongoing bronchospasm may be treated with bronchodilators such as nebulised salbutamol, but always as an addition to adrenaline, never instead of it.
What's no longer first-line, and the blood test to send
The 2021 RCUK guideline removed two drugs from the initial treatment that many doctors still reach for out of habit. Exams know this, which is why they keep appearing as distractors.
Antihistamines (chlorphenamine). RCUK is clear that antihistamines are not part of the initial emergency treatment of anaphylaxis. They do not treat airway, breathing or circulation problems. They may help skin symptoms, but they must never delay adrenaline. Once the patient is stable, a non-sedating oral antihistamine such as cetirizine is preferred to chlorphenamine, because sedation makes it harder to assess a patient who might deteriorate.
Corticosteroids (hydrocortisone). Routine use of corticosteroids is no longer advised. They take hours to work, and RCUK notes there is little evidence that they shorten protracted symptoms or prevent biphasic reactions. RCUK suggests they may be considered only after initial resuscitation, for refractory reactions or ongoing asthma or shock, and never in preference to adrenaline.
Mast cell tryptase. Tryptase is released from mast cells during anaphylaxis and helps the allergy clinic confirm the diagnosis later. NICE NG258 recommends that after suspected anaphylaxis in an adult or young person aged 16 or over you take timed blood samples:
- as soon as possible after emergency treatment has started;
- a second sample ideally within 1–2 hours (but no later than 4 hours) from the onset of symptoms.
RCUK adds a third, baseline sample at least 24 hours after full resolution, which is often taken at the allergy clinic follow-up; NICE says to tell patients that a baseline sample may be needed there. In children under 16, NICE says to consider the same timed samples if the cause is thought to be venom-related, drug-related or idiopathic. Two rules matter in the exam: never delay treatment to take a sample, and a normal tryptase does not exclude anaphylaxis (RCUK notes the rise may not be obvious in food-induced reactions).
What happens next in the UK
This is where the 2026 update to the NICE guideline changed the details, and where exam questions on "discharge" and "the next step after the patient has recovered" come from. NICE NG258 replaced CG134 and adopted the RCUK 2021 observation periods.
Observation. How long the patient stays depends on how severe the reaction was and how much treatment they needed:
- 2 hours (from resolution of airway swelling and normal breathing, with stable BP and heart rate): consider discharge. A good response within 5–10 minutes to a single dose of IM adrenaline given within 30 minutes of onset, symptoms completely resolved, the patient already has 2 in-date auto-injectors and knows how to use them, and adequate supervision afterwards if needed
- At least 6 hours after resolution of all symptoms: 2 doses of IM adrenaline were needed, or there is a history of a biphasic reaction
- At least 12 hours after resolution of all symptoms: Severe anaphylaxis needing more than 2 doses; severe asthma or severe respiratory compromise; possible continuing absorption of the allergen (for example, slow-release medicines); presentation out of hours; the patient may not be able to respond to deterioration; or discharge to an area where emergency care is hard to reach
Children and young people under 16 who can't be discharged under the 2-hour criteria should be admitted under a paediatric team. A biphasic reaction, the return of symptoms after apparent recovery without further exposure, occurs in about 5% of patients, with a median onset of around 12 hours, which is why the observation periods are what they are. RCUK also advises checking for postural dizziness before discharge.
Adrenaline auto-injectors. Before discharge, NICE says the patient must have 2 in-date adrenaline auto-injectors (prescribed if needed) and know when and how to use them, unless the reaction was caused by a drug that can easily be avoided. They should be advised to carry both at all times. The reason for two is simple: one may misfire, be used incorrectly, or not be enough, and a second dose may be needed before the ambulance arrives. Before they leave, a suitably skilled professional should give them:
- information about anaphylaxis and its signs and symptoms, and about the risk of a biphasic reaction;
- advice on avoiding the suspected trigger, if known;
- what to do if it happens again: use the auto-injector and call emergency services (999);
- a brand-specific demonstration of their auto-injector, with the advice to lie down after using it (or sit up if struggling to breathe) and not to stand up or change position suddenly, even if they feel better;
- information about patient support groups and about the referral process.
Allergy clinic referral. NICE recommends offering every adult, young person or child a referral to a specialist allergy service after emergency treatment for suspected anaphylaxis, with separate referral pathways for adults and children in each hospital trust. The allergy clinic confirms the trigger, measures the baseline tryptase, and plans long-term management. RCUK also encourages reporting anaphylaxis events to the UK Anaphylaxis Registry, and drug-induced anaphylaxis should be reported to the MHRA through the Yellow Card scheme.
Try it: an exam-style question
A 34-year-old woman has throat tightness and a hoarse voice 5 minutes after starting intravenous co-amoxiclav on the surgical ward. She has widespread urticaria, lip swelling and wheeze. The infusion has been stopped, help called and high-flow oxygen started. Before oxygen, her temperature was 37.1°C, pulse rate 128 bpm, BP 82/46 mmHg, respiratory rate 28 breaths per minute and oxygen saturation 91% breathing air.
Which is the most appropriate initial treatment?
- A. Intramuscular adrenaline 500 micrograms
- B. Intravenous adrenaline 1 mg
- C. Intravenous chlorphenamine 10 mg
- D. Intravenous hydrocortisone 200 mg
- E. Nebulised salbutamol 5 mg
Decide before reading on.
Answer: A. Intramuscular adrenaline 500 micrograms.
This item tests the first drug in anaphylaxis, according to the Resuscitation Council UK (RCUK) guideline Emergency treatment of anaphylaxis (2021).
The clinical picture
- She had a penicillin intravenously, and the symptoms started within minutes.
- Her airway is affected: throat tightness, a hoarse voice and lip swelling. Her breathing is affected too, with wheeze, a respiratory rate of 28 and a saturation of 91%.
- She is also shocked, with a BP of 82/46 mmHg and a pulse of 128. This is anaphylaxis.
Why intramuscular adrenaline
- The trigger has been stopped, help is coming and oxygen is on. The next step is the drug that reverses the reaction: IM adrenaline 500 micrograms (0.5 mL of 1 mg/mL) for an adult (RCUK), into the anterolateral aspect of the middle third of the thigh.
- Repeat it after 5 minutes if she is no better. Give an IV crystalloid bolus for the low blood pressure, and keep her lying flat.
How the answer changes when the question is twisted
- She is still shocked and wheezy after two correctly given IM doses: this is refractory anaphylaxis. Get critical care help early for a low-dose IV adrenaline infusion run by an experienced specialist.
- She has no pulse: start CPR and follow the cardiac arrest algorithm, where IV adrenaline 1 mg is the right dose.
- The patient is an 8-year-old boy: the IM dose is 300 micrograms (RCUK, ages 6 to 12).
- She takes a beta-blocker and stays refractory despite an adrenaline infusion: RCUK suggests specialists consider glucagon.
Why the others are wrong
- B. Intravenous adrenaline 1 mg: the cardiac arrest dose. RCUK does not recommend IV adrenaline boluses in anaphylaxis unless the patient is in cardiac arrest. Given to a patient with a pulse, it can cause severe hypertension, arrhythmias and myocardial ischaemia.
- C. Intravenous chlorphenamine 10 mg: the urticaria makes an antihistamine feel natural, but antihistamines do not treat airway, breathing or circulation problems. RCUK does not include them in the initial emergency treatment.
- D. Intravenous hydrocortisone 200 mg: no longer given routinely, and it takes hours to act. RCUK suggests a steroid may be considered only after initial resuscitation, for refractory reactions or ongoing asthma or shock.
- E. Nebulised salbutamol 5 mg: may help a wheeze that persists after adrenaline, but it does nothing for the airway swelling or the shock.
How to revise this so it sticks
Anaphylaxis is a short topic with a lot of numbers, and exam questions are written so that you have to pull the right number out under time pressure. A sensible plan:
- Learn the dose table cold, in micrograms and in mL of 1 mg/mL: 500, 300, 150 and 100–150 micrograms. Say the site out loud with it: anterolateral thigh, middle third. Questions often swap one detail (deltoid, subcutaneous, 1 mg, 1:10,000) to see if you notice.
- Practise recognising it without a rash. Write down three scenarios where the skin is normal but the patient is wheezy or hypotensive after a trigger, and three where there is urticaria but no A, B or C problem. Being able to tell them apart is what the exam is testing.
- Know the order of escalation: IM adrenaline, repeat at 5 minutes, fluids, then refractory anaphylaxis with expert help and an IV infusion. Know what's not in that list: antihistamines and steroids.
- Learn the after-care as a story: tryptase (as soon as possible, then 1–2 hours, then baseline), observation (2, 6 or 12 hours), two auto-injectors, and an allergy referral. Discharge questions are some of the easiest marks in the topic once you know the 2026 NICE criteria.
- Do 15–20 timed questions on allergy and emergencies, read the explanation for every option, and repeat the ones you got wrong three days later.
If you're preparing for the clinical exams too, anaphylaxis is a common acute station: you will be expected to recognise it, give the right dose and explain the auto-injector to the patient afterwards. OSCE Revisions has full stations for PLAB 2, UKMLA CPSA and AMC Clinical, with AI patients and examiner-style marking.
Educational content for exam preparation, based on Resuscitation Council UK anaphylaxis guidance and NICE NG258. It is not individual medical advice. Always follow your local guidelines in practice.
Questions
What is the first-line treatment for anaphylaxis in the UK?
IM adrenaline. Resuscitation Council UK recommends adrenaline 1 mg/mL given intramuscularly into the anterolateral thigh as soon as anaphylaxis is suspected, repeated after 5 minutes if the airway, breathing or circulation problems persist.
What is the adult IM adrenaline dose for anaphylaxis?
500 micrograms, which is 0.5 mL of 1 mg/mL (1:1000) adrenaline, for adults and children over 12. RCUK child doses are 300 micrograms (6–12 years), 150 micrograms (6 months to 6 years) and 100–150 micrograms (under 6 months).
Can you have anaphylaxis without a rash?
Yes. Skin and mucosal changes are absent in up to 20% of cases. A sudden airway, breathing or circulation problem after a likely trigger should be treated as anaphylaxis even if the skin is normal.
Are chlorphenamine and hydrocortisone still given in anaphylaxis?
Not as first-line treatment. Antihistamines don't treat airway, breathing or circulation problems; once the patient is stable a non-sedating oral antihistamine can help skin symptoms. Corticosteroids are not given routinely and are considered only after resuscitation for refractory reactions or ongoing asthma or shock.
What is refractory anaphylaxis?
Respiratory or cardiovascular problems that persist despite two appropriate doses of IM adrenaline. It needs early critical care help, a low-dose IV adrenaline infusion started by an experienced specialist, IM adrenaline every 5 minutes until the infusion runs, and IV fluids.
How long should a patient be observed after anaphylaxis?
Under NICE NG258 (2026): consider discharge after 2 hours if a single IM dose worked quickly and the patient has 2 auto-injectors and is trained; at least 6 hours if 2 doses were needed or there is a history of biphasic reaction; at least 12 hours if more than 2 doses were needed, or with severe asthma, out-of-hours presentation or other risk factors.
Sources
- Resuscitation Council UK: Emergency treatment of anaphylaxis, guidelines for healthcare providers (May 2021, PDF)
- RCUK: anaphylaxis guidance page
- RCUK 2025 Resuscitation Guidelines: special circumstances
- NICE NG258: Anaphylaxis, assessment and referral after emergency treatment
- NICE NG258: timing of blood samples
- NICE NG258: period of observation
- NICE NG258: referral to a specialist allergy service
- NICE NG258: discharge from A&E or inpatient care
- NICE NG258: update information
Reviewed by the MedRevisions clinical team
Last reviewed